Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Autor: Wang Y; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dackus GMHE; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Rosenberg EH; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boo LW; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Chan TWS; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong VMT; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Koop E; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Nederlof PM; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van Steenis C; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Salgado RF; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Center, Melbourne, Australia., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.

Publikováno v: BMC medicine [BMC Med] 2024 Jan 09; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2024 Jan 09.